Kelechi Chikere

Analyst Kelechi Chikere, carries an average stock price target met ratio of 38.33% that have a potential upside of 49.06% achieved within 39 days. Previously, Kelechi Chikere worked at JEFFERIES.

Kelechi Chikere’s has documented 21 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ALT, Altimmune at 30-Dec-2021.

Wall Street Analyst Kelechi Chikere

Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 12/23/2020. The price target of $24 was fulfilled within 56 days with a profit of $11.38 (90.17%) receiving and performance score of 16.1.

Average potential price target upside

• of $83.56 (62.14%) on NVAX (NOVAVAX).
• of $11.02 (85.04%) on ALT (ALTIMMUNE).